Gross Profit Margin (Quarterly) Chart

View Gross Profit Margin (Quarterly) for GIPL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit Margin (Quarterly) Chart
Start Trial

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2005. Start Trial.
Date Value
March 31, 2026 87.61%
December 31, 2025 83.33%
September 30, 2025
June 30, 2025
March 31, 2025
December 31, 2024
September 30, 2024
June 30, 2024
March 31, 2024
December 31, 2023
September 30, 2023
June 30, 2023
March 31, 2023
December 31, 2022
September 30, 2022
June 30, 2022
March 31, 2022
December 31, 2021
September 30, 2021
June 30, 2021
March 31, 2021
December 31, 2020
September 30, 2020
Date Value
June 30, 2020
March 31, 2020
December 31, 2019
September 30, 2015
June 30, 2015
March 31, 2015
December 31, 2014
September 30, 2014
June 30, 2014
March 31, 2014
December 31, 2013
September 30, 2013
December 31, 2012
June 30, 2007 -121.9%
March 31, 2007 4.32%
December 31, 2006 31.31%
September 30, 2006 -7.04%
June 30, 2006 8.26%
March 31, 2006 52.07%
December 31, 2005 16.77%
September 30, 2005 -10.20%
June 30, 2005 21.65%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Vaso Corp. 59.81%
Omnicell, Inc. 45.30%
Carlsmed, Inc. 77.10%
MediXall Group, Inc. --
ECGI Holdings, Inc. 11.52%

Gross Profit Margin (Quarterly) Related Metrics